Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 164

Similar articles for PubMed (Select 24237431)

1.

[Investigation of baseline antiviral resistance in treatment-naive chronic hepatitis B cases].

Ergünay K, Kahramanoğlu Aksoy E, Simşek H, Alp A, Sener B, Tatar G, Us D, Hasçelik G.

Mikrobiyol Bul. 2013 Oct;47(4):628-35. Turkish.

2.

4'-modified nucleoside analogs: Potent inhibitors active against entecavir-resistant hepatitis B virus.

Takamatsu Y, Tanaka Y, Kohgo S, Murakami S, Singh K, Das D, Venzon DJ, Amano M, Kuwata N, Aoki M, Delino NS, Hayashi S, Takahashi S, Sukenaga Y, Haraguchi K, Sarafianos SG, Maeda K, Mitsuya H.

Hepatology. 2015 Jun 29. doi: 10.1002/hep.27962. [Epub ahead of print]

PMID:
26122273
3.

Prevalence and types of drug-resistant variants in Chinese patients with acute hepatitis B.

Su F, Dai J, Yang S, Jiang X, Cui X, Ning H, Li J, Huang M.

J Med Virol. 2015 May 29. doi: 10.1002/jmv.24006. [Epub ahead of print]

PMID:
26032700
5.

Microarray-based genotyping and detection of drug-resistant HBV mutations from 620 Chinese patients with chronic HBV infection.

Hua W, Zhang G, Guo S, Li W, Sun L, Xiang G.

Braz J Infect Dis. 2015 May-Jun;19(3):291-5. doi: 10.1016/j.bjid.2015.03.012. Epub 2015 May 14.

7.

Response to potent anti-HBV agents in chronic hepatitis B and combined effect of HBV reverse transcriptase mutations.

Singla B, Bhattacharyya R, Chakraborti A, Sharma BK, Kapil S, Chawla YK, Arora SK, Das A, Dhiman RK, Duseja A.

Gene. 2015 Aug 1;567(1):22-30. doi: 10.1016/j.gene.2015.04.060. Epub 2015 Apr 24.

PMID:
25917965
8.

Immune-driven adaptation of hepatitis B virus genotype D involves preferential alteration in B-cell epitopes and replicative attenuation-an insight from human immunodeficiency virus/hepatitis B virus coinfection.

Mondal RK, Khatun M, Ghosh S, Banerjee P, Datta S, Sarkar S, Saha B, Santra A, Banerjee S, Chowdhury A, Datta S.

Clin Microbiol Infect. 2015 Jul;21(7):710.e11-20. doi: 10.1016/j.cmi.2015.03.004. Epub 2015 Apr 13.

PMID:
25882358
9.

Naturally occurring deletions/insertions in HBV core promoter tend to decrease in HBeAg-positive chronic hepatitis B patients during antiviral therapy.

Peng Y, Liu B, Hou J, Sun J, Hao R, Xiang K, Yan L, Zhang J, Zhuang H, Li T.

Antivir Ther. 2015 Apr 2. doi: 10.3851/IMP2955. [Epub ahead of print]

PMID:
25838313
10.

Pre-existing mutations in reverse transcriptase of hepatitis B virus in treatment-naive Chinese patients with chronic hepatitis B.

Xu J, Wu B, Wang JH, Huang L, Wang DY, Zhao L, Zhao GP, Wang Y.

PLoS One. 2015 Mar 30;10(3):e0117429. doi: 10.1371/journal.pone.0117429. eCollection 2015.

11.

New amino acid changes in drug resistance sites and HBsAg in hepatitis B virus genotype H.

Fernández-Galindo DA, Sánchez-Ávila F, Bobadilla-Morales L, Gómez-Quiróz P, Bueno-Topete M, Armendáriz-Borunda J, Sánchez-Orozco LV.

J Med Virol. 2015 Jun;87(6):985-92. doi: 10.1002/jmv.24098. Epub 2015 Mar 2.

PMID:
25732900
12.

HBV carrying drug-resistance mutations in chronically infected treatment-naive patients.

Gomes-Gouvêa MS, Ferreira AC, Teixeira R, Andrade JR, Ferreira AS, Barros LM, Rezende RE, Nastri AC, Leite AG, Piccoli LZ, Galvan J, Conde SR, Soares MC, Kliemann DA, Bertolini DA, Kunyoshi AS, Lyra AC, Oikawa MK, de Araújo LV, Carrilho FJ, Mendes-Corrêa MC, Pinho JR.

Antivir Ther. 2015 Jan 27. doi: 10.3851/IMP2938. [Epub ahead of print]

PMID:
25624410
13.

Use of nucleoside analogs in patients with chronic hepatitis B in Nepal: A prospective cohort study in a single hospital.

Masaki N, Shrestha PK, Nishimura S, Ito K, Sugiyama M, Mizokami M.

Hepatol Res. 2015 Jan 12. doi: 10.1111/hepr.12482. [Epub ahead of print]

PMID:
25581418
14.

[Effect of human concentration nucleoside transporters 1 and multi-drug resistance protein 4 gene polymorphism on response of chronic hepatitis B to nucleoside analogues treatment].

Wang WZ, Lu LX, Li DJ, Lu JJ, He M, Liu C, Tang H, Wang LC.

Sichuan Da Xue Xue Bao Yi Xue Ban. 2014 Nov;45(6):950-5. Chinese.

PMID:
25571722
15.

Antiviral treatment among pregnant women with chronic hepatitis B.

Fan L, Owusu-Edusei K Jr, Schillie SF, Murphy TV.

Infect Dis Obstet Gynecol. 2014;2014:546165. doi: 10.1155/2014/546165. Epub 2014 Dec 7.

16.

First hepatitis B virus full-length genomic study among blood donors from Argentina: unexpected mutations in the circulating subgenotypes' proteins.

Delfino CM, Berini C, Pedrozo W, Malan R, Blejer J, Oubiña JR, Biglione MM, Mathet VL.

Virus Genes. 2015 Apr;50(2):286-91. doi: 10.1007/s11262-014-1159-4. Epub 2014 Dec 24.

PMID:
25537951
17.

Nucleotide analogue-resistant mutations in hepatitis B viral genomes found in hepatitis B patients.

Fan J, Zhang Y, Xiong H, Wang Y, Guo X.

J Gen Virol. 2015 Mar;96(Pt 3):663-70. doi: 10.1099/jgv.0.000010. Epub 2014 Dec 6.

PMID:
25481755
18.

A deep-sequencing method detects drug-resistant mutations in the hepatitis B virus in Indonesians.

Widasari DI, Yano Y, Heriyanto DS, Utsumi T, Yamani LN, Rinonce HT, Wasityastuti W, Lusida MI, Soetjipto, Okada R, Murakami Y, Tanahashi T, Azuma T, Hayashi Y.

Intervirology. 2014;57(6):384-92. doi: 10.1159/000366420. Epub 2014 Oct 31.

PMID:
25382636
19.

Impact of a new reimbursement program on hepatitis B antiviral medication cost and utilization in Beijing, China.

Qiu Q, Li Y, Duan XW, Yang LK, Chen Y, Li H, Wang L, Duan ZP.

PLoS One. 2014 Oct 16;9(10):e109652. doi: 10.1371/journal.pone.0109652. eCollection 2014.

20.

Incidence of natural resistance mutations in naïve chronic hepatitis B patients: a systematic review and meta-analysis.

Zhang Q, Liao Y, Cai B, Li Y, Li L, Zhang J, An Y, Wang L.

J Gastroenterol Hepatol. 2015 Feb;30(2):252-61. doi: 10.1111/jgh.12831.

PMID:
25318660
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk